Table 1.
A standard immunohistochemistry (IHC) panel for the three main clinical biomarkers ER, PR, and HER2 can approximate the four intrinsic breast cancer molecular subtypes.
Breast cancer subtype | ER | PR | HER2 | Triple designation |
---|---|---|---|---|
Luminal A | + | ± | − | ER+PR±HER2− |
Luminal B | + | ± | + | ER+PR±HER2+ |
HER2+ | − | − | + | ER−PR−HER2+ |
Basal-like | − | − | − | ER−PR−HER2− |